Douglas G Janzen, Chairman & Chief Executive Officer at Aequus Pharmaceuticals, holds 12.55M shares in Aequus Pharmaceuticals (Ticker: TSE:AQS), holds 182.50K shares in Correvio Pharma (Ticker: CORV), holds 38.89K shares in Neovasc (Ticker: NVCN). Most recently, Douglas G Janzen Bought ― shares of Aequus Pharmaceuticals on Dec 01, 2022 for an estimated value of 14.85K.